Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 and is expected to grow at a CAGR of 12% over the next three years
July 26, 2018 01:49 ET
|
Market Reports Center
NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Market Reports Center’s research has new report titled “Big Data in the Healthcare & Pharmaceutical Industry: 2018 2030 : Opportunities, Challenges,...
The Alliance for Regenerative Medicine Publishes Position on Proposed Regulation on Health Technology Assessment and Amending Directive 2011/24/EU
July 11, 2018 11:05 ET
|
Alliance for Regenerative Medicine
BRUSSELS, Belgium and WASHINGTON, D.C., July 11, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing multiple stakeholder...
Pacific Biosciences Selected for NSF Project to Rapidly Sequence Maize Pangenome
July 10, 2018 07:30 ET
|
Pacific Biosciences, Inc.
MENLO PARK, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and...
Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
July 05, 2018 16:05 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program
June 07, 2018 07:30 ET
|
Pacific Biosciences, Inc.
MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has...
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
June 07, 2018 07:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic...
Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria
June 06, 2018 04:00 ET
|
Pacific Biosciences, Inc.
HINXTON, United Kingdom and MENLO PARK, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by...
Fluidigm Releases Sample Identification Genotyping Panel for Translational and Clinical Research
June 05, 2018 06:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ Sample ID Genotyping Panel for the identification...
OmniSeq and LabCorp Launch OmniSeq Advance℠ Assay
June 01, 2018 16:11 ET
|
OmniSeq
CHICAGO, June 01, 2018 (GLOBE NEWSWIRE) -- ASCO – OmniSeq®, a CAP-accredited, molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, and LabCorp® (NYSE:LH), a leading...
The Alliance for Regenerative Medicine and Informa Pharma Intelligence to Host Regenerative Medicine Advanced Therapy Designation Webinar on June 13, 2018
May 29, 2018 12:09 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., May 29, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced it will co-host a webinar titled “RMAT Designation – Impact on the Regenerative...